Immunovant, Inc. (IMVT) Share-based Payment Arrangement, Expense USD 2018 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Immunovant, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2018 to 2024.
  • Immunovant, Inc. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2024 was $9.66 M, a 28.8% increase year-over-year.
  • Immunovant, Inc. Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2024 was $41 M, a 28.3% increase year-over-year.
  • Immunovant, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $41 M, a 28.3% increase from 2022.
  • Immunovant, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $32 M, a 3.55% decline from 2021.
  • Immunovant, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $33.1 M, a 77.8% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $41 M $9.66 M +$2.16 M +28.8% Jan 1, 2024 Mar 31, 2024 10-K 2024-05-29
Q4 2023 $38.9 M $10.2 M +$1.34 M +15.1% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-12
Q3 2023 $37.5 M $10.5 M +$2.45 M +30.4% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $35.1 M $10.7 M +$3.1 M +41% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $32 M $7.5 M -$4.2 M -35.9% Jan 1, 2023 Mar 31, 2023 10-K 2024-05-29
Q4 2022 $36.2 M $8.86 M -$1.1 M -11% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-12
Q3 2022 $37.3 M $8.05 M +$382 K +4.98% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $36.9 M $7.56 M +$3.74 M +97.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $33.1 M $11.7 M +$6.28 M +116% Jan 1, 2022 Mar 31, 2022 10-K 2023-05-22
Q4 2021 $26.9 M $9.95 M +$3.96 M +66.1% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-03
Q3 2021 $22.9 M $7.67 M +$4.36 M +132% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-04
Q2 2021 $18.5 M $3.82 M -$98 K -2.5% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-05
Q1 2021 $18.6 M $5.42 M +$3.62 M +201% Jan 1, 2021 Mar 31, 2021 10-K 2022-06-08
Q4 2020 $15 M $5.99 M +$4.66 M +350% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-04
Q3 2020 $10.4 M $3.31 M +$188 K +6.03% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 $10.2 M $3.92 M +$3.38 M +630% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $6.79 M $1.8 M Jan 1, 2020 Mar 31, 2020 10-K 2021-06-01
Q4 2019 $1.33 M +$1.32 M +11000% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-16
Q3 2019 $3.12 M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 $537 K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-12
Q4 2018 $12 K* Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.